1
|
Zhang XH, Teng XB, Shi JF, Han MF. Severe novel coronavirus pneumonia: Clinical characteristics and risk factors. Asian J Surg 2023; 46:4662-4663. [PMID: 37271642 PMCID: PMC10213296 DOI: 10.1016/j.asjsur.2023.04.148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2023] [Accepted: 04/12/2023] [Indexed: 06/06/2023] Open
Affiliation(s)
- Xiao-Hua Zhang
- Department of Respiratory and Critical Care Medicine, The Second People's Hospital of Fuyang City, Fuyang, 236015, China
| | - Xiao-Bao Teng
- Department of Respiratory and Critical Care Medicine, The Second People's Hospital of Fuyang City, Fuyang, 236015, China
| | - Jing-Feng Shi
- Department of Respiratory and Critical Care Medicine, The Second People's Hospital of Fuyang City, Fuyang, 236015, China
| | - Ming-Feng Han
- Department of Respiratory and Critical Care Medicine, The Second People's Hospital of Fuyang City, Fuyang, 236015, China.
| |
Collapse
|
2
|
Xiao B, Sun LL, Yuan J, Xiao WL, Liu Y, Cai MY, Liao QH. Investigation of a Mask Fitness Test Based on Self-Efficacy and Diversified Training in the Assessment System for Nosocomial Infection Training. Infect Drug Resist 2023; 16:313-322. [PMID: 36691491 PMCID: PMC9863456 DOI: 10.2147/idr.s388784] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2022] [Accepted: 12/14/2022] [Indexed: 01/18/2023] Open
Abstract
Objective To explore a mask fitness test based on self-efficacy and diversified training in the assessment system for nosocomial infection training. Methods From March 15 to April 5, 2022, 442 staff members (272 male and 170 female) of the Third People's Hospital of Shenzhen who planned to enter the quarantine ward for secondary protection skill training assessment were selected. They comprised 56 doctors, 31 medical technicians, 72 nurses, and 283 property logistics staff. During the mask fitness test, a diversified training model based on self-efficacy was adopted to observe the passing status, the identification and selection of mask models, the method of mask-wearing, the fit between the mask and the face, and the changes in self-efficacy. Results In the assessment system for nosocomial infection training, the passing rate of the mask fitness test was correlated with the identification and selection of mask models, the method of wearing masks, the fit between the mask and the face, and the diversified training, and the differences were statistically significant (P < 0.05). The difference in the self-efficacy in the test takers between those before and after the mask fitness test was statistically significant (P < 0.05). Conclusion In the assessment system for nosocomial infection training, the mask fitness test based on self-efficacy and diversified training might improve the passing rate, the rate of correct mask model identification and selection, the rate of correct mask-wearing, and the degree of facial fit, thus to enhance the awareness of protection and improve self-efficacy.
Collapse
Affiliation(s)
- Bing Xiao
- Department of Outpatient, the Third People’s Hospital of Shenzhen, Shenzhen, 518000, People’s Republic of China
| | - Lu-Lu Sun
- Department of Pediatric, the Third People’s Hospital of Shenzhen, Shenzhen, 518000, People’s Republic of China,Correspondence: Lu-Lu Sun, Department of Pediatric, the Third People’s Hospital of Shenzhen, No. 29 of Bulan Road, Longgang District, Shenzhen, 518000, People’s Republic of China, Tel +86 13510332310, Email
| | - Jing Yuan
- Department of Infectious Diseases, the Third People’s Hospital of Shenzhen, Shenzhen, 518000, People’s Republic of China
| | - Wan-Ling Xiao
- Department of Outpatient, the Third People’s Hospital of Shenzhen, Shenzhen, 518000, People’s Republic of China
| | - Ying Liu
- GI Medicine Department, the Third People’s Hospital of Shenzhen, Shenzhen, 518000, People’s Republic of China
| | - Man-Yuan Cai
- Science and Education Department, the Third People’s Hospital of Shenzhen, Shenzhen, 518000, People’s Republic of China
| | - Qiao-Huo Liao
- Department of Pediatric, the Third People’s Hospital of Shenzhen, Shenzhen, 518000, People’s Republic of China
| |
Collapse
|
3
|
Jin HT, Wang F, Zhang W, Liu QL, Zhang JL, Yu M, Guo ZZ, Pan W. Linear Regression Analysis of Sleep Quality in People with Insomnia in Wuhan City during the COVID-19 Pandemic. Int J Clin Pract 2023; 2023:6746045. [PMID: 37066072 PMCID: PMC10104741 DOI: 10.1155/2023/6746045] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/09/2022] [Revised: 02/20/2023] [Accepted: 03/22/2023] [Indexed: 04/18/2023] Open
Abstract
Objective COVID-19 has evolved into a major global public health event. The number of people reporting insomnia is growing exponentially during the pandemic. This study aimed to explore the relationship between aggravated insomnia and COVID-19-induced psychological impact on the public, lifestyle changes, and anxiety about the future. Methods In this cross-sectional study, we used the questionnaires from 400 subjects who were obtained from the Department of Encephalopathy of the Wuhan Hospital of Traditional Chinese Medicine between July 2020 and July 2021. The data collected for the study included demographic characteristics of the participants and psychological scales consisting of the Spiegel Sleep Questionnaire, the Fear of COVID-19 Scale (FCV-19S), the Zung Self-Rating Anxiety Scale (SAS), and the Zung Self-Rating Depression Scale (SDS). The independent sample t-test and one-way ANOVA were used to compare the results. Correlation analysis of variables affecting insomnia was performed using Pearson correlation analysis. The degree of influence of the variables on insomnia was determined using linear regression, and a regression equation was derived. Results A total of 400 insomnia patients participated in the survey. The median age was 45.75 ± 15.04 years. The average score of the Spiegel Sleep Questionnaire was 17.29 ± 6.36, that of SAS was 52.47 ± 10.39, that of SDS was 65.89 ± 8.72, and that of FCV-19S was 16.09 ± 6.81. The scores of FCV-19S, SAS, and SDS were closely related to insomnia, and the influencing degree was in the following order: fear, depression, and anxiety (OR = 1.30, 0.709, and 0.63, respectively). Conclusion Fear of COVID-19 can be one of the primary contributors to worsening insomnia.
Collapse
Affiliation(s)
- Hai-Tao Jin
- Department of Encephalopathy, The Traditional Chinese Medicine Hospital of Wuhan, Wuhan, Hubei 430014, China
| | - Fei Wang
- Department of Encephalopathy, The Traditional Chinese Medicine Hospital of Wuhan, Wuhan, Hubei 430014, China
| | - Wen Zhang
- Department of Encephalopathy, The Traditional Chinese Medicine Hospital of Wuhan, Wuhan, Hubei 430014, China
| | - Qi-Lin Liu
- Department of Encephalopathy, The Traditional Chinese Medicine Hospital of Wuhan, Wuhan, Hubei 430014, China
| | - Jing-Lan Zhang
- Department of Encephalopathy, The Traditional Chinese Medicine Hospital of Wuhan, Wuhan, Hubei 430014, China
| | - Miao Yu
- Clinical College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuchang, Wuhan, Hubei 430065, China
| | - Zhen-Zhen Guo
- Clinical College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuchang, Wuhan, Hubei 430065, China
| | - Wei Pan
- Department of Encephalopathy, The Traditional Chinese Medicine Hospital of Wuhan, Wuhan, Hubei 430014, China
| |
Collapse
|
4
|
Liang J, Zheng M, Xu W, Chen Y, Tang P, Wu G, Zou P, Li H, Chen L. Acriflavine and proflavine hemisulfate as potential antivirals by targeting M pro. Bioorg Chem 2022; 129:106185. [PMID: 36240541 PMCID: PMC9540699 DOI: 10.1016/j.bioorg.2022.106185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2022] [Revised: 09/18/2022] [Accepted: 09/26/2022] [Indexed: 11/02/2022]
Abstract
The evolving SARS-CoV-2 epidemic buffets the world, and the concerted efforts are needed to explore effective drugs. Mpro is an intriguing antiviral target for interfering with viral RNA replication and transcription. In order to get potential anti-SARS-CoV-2 agents, we established an enzymatic assay using a fluorogenic substrate to screen the inhibitors of Mpro. Fortunately, Acriflavine (ACF) and Proflavine Hemisulfate (PRF) with the same acridine scaffold were picked out for their good inhibitory activity against Mpro with IC50 of 5.60 ± 0.29 μM and 2.07 ± 0.01 μM, respectively. Further evaluation of MST assay and enzymatic kinetics experiment in vitro showed that they had a certain affinity to SARS-CoV-2 Mpro and were both non-competitive inhibitors. In addition, they inhibited about 90 % HCoV-OC43 replication in BHK-21 cells at 1 μM. Both compounds showed nano-molar activities against SARS-CoV-2 virus, which were superior to GC376 for anti-HCoV-43, and equivalent to the standard molecule remdesivir. Our study demonstrated that ACF and PRF were inhibitors of Mpro, and ACF has been previously reported as a PLpro inhibitor. Taken together, ACF and PRF might be dual-targeted inhibitors to provide protection against infections of coronaviruses.
Collapse
Affiliation(s)
- Jing Liang
- Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China
| | - Mengzhu Zheng
- School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - Wei Xu
- Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China
| | - Yongkang Chen
- Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China
| | - Piyu Tang
- Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China
| | - Guoyi Wu
- Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China,Corresponding authors at: Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China (H. Li and L. Chen)
| | - Peng Zou
- Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China,Corresponding authors at: Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China (H. Li and L. Chen)
| | - Hua Li
- Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China,Institute of Structural Pharmacology & TCM Chemical Biology, College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China,School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China,Corresponding authors at: Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China (H. Li and L. Chen)
| | - Lixia Chen
- Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China,Corresponding authors at: Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China (H. Li and L. Chen)
| |
Collapse
|
5
|
Xu T, Li Z, Li H, Hou J, Li J, Jin G, Li S, Li Q. Dynamic changes in the body composition during chemotherapy for gastrointestinal tumors in the context of active nutrition intervention. Front Oncol 2022; 12:965848. [DOI: 10.3389/fonc.2022.965848] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2022] [Accepted: 10/17/2022] [Indexed: 12/03/2022] Open
Abstract
ObjectiveTo explore the dynamic changes in the body composition during chemotherapy in patients with gastrointestinal malignancies in the context of active nutrition intervention.MethodsPatients with gastrointestinal malignancies receiving first-line chemotherapy in the Department of Medical Oncology of Ordos Central Hospital from September 2019 to January 2022 were included in this study. The Nutritional Risk Screening form 2002, Patient-Generated Subjective Global Assessment form, bioelectrical impedance analysis, and dynamic changes in L3 skeletal muscle index (SMI) (L3SMI) were assessed at baseline and after chemotherapy. The recommended protocol of the Nutrition Guidelines for Cancer Patients in China 2020 was adopted as the active nutrition intervention. Chemotherapy-related toxic adverse reactions and the degree of toxicity were recorded with the adoption of the Common Terminology Criteria for Adverse Events version 4.0 by the National Institutes of Health. The type of toxicity Chemotherapy-Induced Nauseaand Vomiting(CINV) and hematological.ResultsFifty cases were enrolled in the study, and 38 cases completed the dynamic follow-ups. The average follow-up time was 125.63 d. In the context of active nutrition intervention, the prevalence of sarcopenia decreased from 26.3% before chemotherapy to 21.1% after chemotherapy. The average L3SMI decreased from 38.77 cm2/m2 to 38.04 cm2/m2, with a reduction of 1.41% ± 8.49% (P = 0.177). The SMI remained stable or increased in 57.9% (22/38) of patients. The benefit of active nutrition intervention was greater in the sarcopenic group than in the non-sarcopenic group (P = 0.033). There was an increased incidence of chemotherapy-related toxic adverse reactions of ≥ grade 3 during chemotherapy in the sarcopenic group compared with the muscle retention/gain group (P = 0.089).ConclusionActive nutrition intervention might decrease the degree of reduction of L3SMI and the incidence of sarcopenia in patients with gastrointestinal tumors and raise the proportion of patients with stable or increased SMI during chemotherapy.
Collapse
|
6
|
Ma X, Lu ZY, Qu YJ, Xing LH, Zhang Y, Lu YB, Dong L, Li HJ, Li L, Yin XP, Xu CJ. Differences in Clinical and Imaging Features between Asymptomatic and Symptomatic COVID-19 Patients. Int J Clin Pract 2022; 2022:4763953. [PMID: 36620481 PMCID: PMC9771641 DOI: 10.1155/2022/4763953] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/12/2022] [Revised: 09/13/2022] [Accepted: 10/08/2022] [Indexed: 12/15/2022] Open
Abstract
OBJECTIVES The clinical and imaging features of asymptomatic carriers of severe acute respiratory syndrome coronavirus 2 and symptomatic COVID-19 patients. METHODS The clinical and chest computed tomography imaging data of 47 asymptomatic carriers and 36 symptomatic COVID-19 patients were derived. All patients underwent 4-6 CT scans over a period of 2-5 days. RESULTS The bulk of asymptomatic carriers who developed symptoms and most of the COVID-19 patients were older than 18 years of age with a decreased lymphocyte count, abnormal hepatic and renal function, and increased D-dimer and C-reactive protein. In the early stage, the pulmonary lesion involved mostly 1-2 lobes at the peripheral area in asymptomatic carriers but more than three lobes at both the central and peripheral areas in COVID-19 patients. In the progression stage, the lesion of asymptomatic carriers extended from the peripheral to the central area, and no significant difference was found in the lesion range compared with the symptomatic control group. In early improvement stage, the lesion was rapidly absorbed, and lesions were located primarily at the peripheral area in asymptomatic carriers; contrastingly, lesions were primarily located at both the central and peripheral areas in symptomatic patients. Asymptomatic carriers reflected a significantly shorter duration from disease onset to peak progression stage compared with the symptomatic. CONCLUSIONS Asymptomatic carriers are a potential source of transmission and may become symptomatic COVID-19 patients despite indicating less severe pulmonary damage, earlier improvement, and better prognosis. Early isolation and intervention can eliminate such carriers as potential sources of transmission and improve their prognosis.
Collapse
Affiliation(s)
- Xi Ma
- CT/MRI Room, Affiliated Hospital of Hebei University, Baoding, Hebei Province 071000, China
| | - Zhi-Yan Lu
- Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province 430071, China
| | - Yan-Juan Qu
- Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province 430071, China
| | - Li-Hong Xing
- CT/MRI Room, Affiliated Hospital of Hebei University, Baoding, Hebei Province 071000, China
| | - Yu Zhang
- CT/MRI Room, Affiliated Hospital of Hebei University, Baoding, Hebei Province 071000, China
| | - Yi-Bo Lu
- Department of Radiology, The Fourth People's Hospital of Nanning City, Nanning, Guangxi 530023, China
| | - Li Dong
- Department of Radiology, Baoding People's Hospital, Baoding 071000, China
| | - Hong-Jun Li
- Department of Radiology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China
| | - Li Li
- Department of Radiology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China
| | - Xiao-Ping Yin
- CT/MRI Room, Affiliated Hospital of Hebei University, Baoding, Hebei Province 071000, China
| | - Chuan-Jun Xu
- Department of Radiology, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province 210003, China
| |
Collapse
|